\1 Introduction
During the past few years, many pregnant women have received prolonged administration of betamimetic drugs. This therapy does not seem to cause changes in the glycemic balance or in hepatic function of the newborn [3] . In the fetus some side effects due to betamimetic drugs have been described [4, 5, 6, 7] , RENAUD [6, 7] noticed that sometimes the fetal heart beats faster. However NOCHIMSON [5] could not observe such effects. Elevated blood levels of glucose and insulin have been described [4, 7] and it has been suggested that increased glycogenolysis is involved [7] , According to RENAUD [7] this is accompanied by increased lipolysis and a falling of pH and base excess. Before asserting the safety of such treatment, it is important to confirm that there are no long-term effects upon live-born infants who may have been exposed to beta-mimetics in utero. This was our aim in studying those infants whose mothers had been treated with ritodrine hydrochloride (Prepar®): a beta-mimetic commonly used by our obstetric colleagues.
Materials and methods
Two groups were studied: one of infants born to mothers treated with ritodrine and the other of Statistical analysis comparing, pair by pair, the children of treated and untreated mothers was performed by applying the appropriate Statistical tests on the basis of the Tab. II.
Results
The two groups of infants were comparable with the exception of duration of gestation at delivery and birth weight (Tab. III).
The possible reason for this is discussed below. The mean age of the two groups at the time of examination was 24.8 months (Tab. IV). The distribution of the pairs was:
1. 12-17 months: 16% 2. 18-23 months: 34% 3. 24-29 months: 28% 4. 30-36 months: 22% Increase in height and weight was not affected by ritodrine, äs is shown in Tab. IV.
Tab. II. Pair by pair Statistical analysis. a = the number of pairs for which the child of the treated mother and the control are both normal äs far äs the examination in question is concerned. b = the number of pairs for which the child of the treated mother is considered to be abnormal and the control child is judged to be normal, c = the number of pairs for which the child of the treated mother is considered to be normal and control child is judged to be abnormal, d = the number of pairs for which both children are considered to be abnormal. There was also no difference in the distribution of physical abnormalities between the two groups (Tab. V). The incidence of infections was almost identical for the two groups. There were no marked differences in the incidence of diseases of the respiratory, digestive, cardiovascular, urino-genital and skeletal Systems äs shown in Tab. VI. Similarly, there was no difference in the incidence of diseases of the central nervous system, or psychiatric disorders between the two groups. Examination of the children's environment and upbringing,. both of which may have serious repercussions on the psychomotor development of a child, revealed no significant differences between the groups. When the actual psychomotor development of the groups was compared, there were no differences in the ages at which the main milestones were attained (Tab. VII).
Infants born to
Analysis of the Denver tests confirmed this: there were no pathological results althöugh three were doubtful in each group. There was no significant difference (P = 0.69, one-sided Sign test). No child häd proteiriuria or glycosuria, and the ürinäry sediment was normal in every case. The electrocardiograms (B.C.G.) showedno change in 36 of the infants from treated mothers, and 34 of the matched controls (P = 0.81, one-sided Sign test). Among the E.C.G. changes noted in the group of infants from treated mothers were :
1. One case of shortening of the P-R interval. 2. 2 cases of inverted T waves in lead V4. 3. One case of left ventricular hypertrophy.
This last patient was re-examined more than a year after the first examination. At this time there were no functional signs, but ehest X-ray was reported äs showing moderate left ventricular hypertrophy.
Tab. V. Distribution of abnormalities for the two groups of infants.
Abnormalities System
Infants of treated mothers Matched controls P-value (one-sided) signTest Blood pressure was 120/80 mmHg when taken on all four limbs. This child will be followed up, since the Interpretation is difficult. The patient has also had a cystic lymphangioma excised from the neck.
Discussion
The difference in duration of gestation at birth, and birth weight, are to be expected. The infants from ritodrine-treated mothers represent a threatened group, otherwise the mothers would not have been given therapy, whereas the controls are not. It is interesting, in this context, to note that this difference in weight had disappeared by the time of examination. If beta-mimetics induced an increase in pre-natal mortality this would introduce a grave error in our study which only concerns live-born children. Our obstetric colleagues state that, according to their experience, this is certainly not so [6].
There was no statistically significant difference in the incidence of pathologies, the psychomotor development, the clinical examination and other investigations, between the two groups of infants.
If any discrepancy had been found it could have been due either to the direct action of ritrodrine hydrochloride or the factors which initiate premature labour. To separate and weigh these possible aetiologies, would have been extremely difficult: fortunately it was not necessary.
Conclusion
The administration of ritodrine hydrochloride to pregnant women is not associated with any harmful effects to the live-born child. We would like to see this work confirmed in other centres. 
Summary
The administration of beta-mimetic drugs to pregnant women poses the problem of possible long-term repercussions in the children born to these mothers. 42 children from women who had been treated with 60-80 mg a day of ritodrine hydrochloride (Pre-par®), during a period varying from 3 to 93 day s, were closely matched with infants from untreated mothers. Each child, (aged from one to 3 years), was fully investigated on the basis of: a detailed questionnaire to the mother; careful clinical examination; assessment of psychomotor development; t^e Denver test; electrocardiography and urine analysis. Theie was no statistically significant diffeience between the two groups for any of the variables of development that were studied. One child had left ventricular hypertrophy, which was probably incidental. It is concluded that administration of ritodrine hydrochloride to pregnant women induces no harmful longterm effects in their off spring.
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